The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, months before they were abruptly fired by U.S. Health Secretary Robert F ...

Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new recommendations for the use of RSV vaccines in the upcoming respiratory ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna shares were up 5.9% on Wednesday, while Pfizer was up 1%. GSK’s American ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following the advice of a recently fired panel of government vaccine advisers. The ...

The first vaccines to guard against the respiratory illness RSV will soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots.. The ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the use of respiratory syncytial virus vaccines in adults aged between 50 and ...

MADISON, Wis. -- The Centers for Disease Control and Prevention announced Wednesday it has updated its recommendations for the use of RSV vaccines in people ages 60 and older. The CDC now ...

The endorsement from CDC Director Dr. Rochelle Walensky follows recommendations from the agency’s independent vaccine advisory committee and approvals from the US Food and Drug Administration ...

CDC issues new guidelines for RSV vaccines, citing side-effect concerns. Nicoletta Lanese. Tue, August 6, 2024 at 7:36 PM UTC. 4 min read. When you buy through links on our articles, Future and ...

In today's health headlines, the CDC changes its RSV vaccine recommendations, fruits and vegetables may have the power to reduce the risk for some serious diseases and emergency medicine doctors ...

In the United States each year, RSV leads to as many as 80,000 hospitalizations in children younger than 5 and up to 160,000 hospitalizations in adults 65 and older, the CDC reports.

The endorsement from CDC Director Dr. Rochelle Walensky follows recommendations from the agency’s independent vaccine advisory committee and approvals from the US Food and Drug Administration.